Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HTFL vs ARX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ARX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)
ARX Overall Winner
6-Pillar Tally: HTFL 0 – 6 ARX
Matrix Metrics: HTFL 2 – 8 ARX
As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Heartflow, Inc. (HTFL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HTFL carries a Unified Composite Score of 55.4/100 (HOLD) at $46.86 (N/M Forward P/E, -30.0% operating margin), whereas ARX carries 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin).
- Composite vs. Pillar Nuance: While HTFL currently prints a higher short-term Unified Composite Score (55.4/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.7% vs. -30.0% operating margin) and revenue trajectory (+6.1% vs. +57.4% YoY).
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HTFL vs ARX
HTFL
Heartflow, Inc. Common Stock
$46.86
-3.3% 1D
Market Cap
$4.3B
TTM Revenue
$239M
Forward P/E
N/M
Beta / 30D Vol
1.48β · 96% Vol
Unified Composite Score
55.4
HOLD
Tech 36.0
Fund 54.0
Flow 65.0
Mom 70.0
Weinstein Technical Phase
Neutral · Hold
ARX
Head-to-Head Winner
Accelerant Holdings
$19.87
+0.1% 1D
Market Cap
$4.3B
TTM Revenue
$2.79B
Forward P/E
21.3x
Beta / 30D Vol
-0.19β · 2% Vol
Unified Composite Score
46.9
HOLD
Tech 34.0
Fund 50.0
Flow 76.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (HTFL 0 – 6 ARX)
1. Valuation Multiples
ARX
Forward P/E
N/M
21.3x
Trailing P/E
72.3x
27.6x
PEG Ratio
N/M
N/M
EV / Revenue
17.8x
N/M
2. Growth & Scale
ARX
Revenue Growth (YoY)
+57.4%
+6.1%
Earnings Growth (YoY)
+0.0%
+800.0%
TTM Revenue (USD)
$239M
$2.79B
Market Cap
$4.3B
$4.3B
3. Profitability & Quality
ARX
Gross Margin
81.8%
62.8%
Operating Margin
-30.0%
3.7%
Net Profit Margin
-33.1%
5.6%
Return on Equity (ROE)
-29.4%
9.2%
4. Balance Sheet & Cash Flow
ARX
Cash Generation (TTM)
-$59M
$634M
Cash Flow Margin
-24.8%
22.7%
Net Cash / Leverage
$7.2M Net Cash
$5.13B Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ARX
Options Structure Phase
CONSOLIDATION
CONSOLIDATION
Current IV / %ile
91.3% (43rd %ile)
15.7% (3rd %ile)
Put/Call OI Skew
2.19x (Put-Skewed)
0.01x (Call-Skewed)
OBV Trend / Tech Phase
ACCUMULATION · Neutral
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
ARX
OpEx & R&D Intensity
N/A
59.1% of Rev ($1.65B)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Health Information Services Operator
Insurance Brokers Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HTFL (2) vs ARX (8)| Institutional Metric | HTFL | ARX | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $4.3B | $4.3B | ARX | |
| Trailing P/E Ratio | 72.3x | 27.6x | ARX | |
| Forward P/E Ratio | N/M | 21.3x | ARX | |
| Revenue Growth (YoY) | +57.4% | +6.1% | HTFL | |
| Operating Margin (TTM) | -30.0% | 3.7% | ARX | |
| Net Profit Margin | -33.1% | 5.6% | ARX | |
| Return on Equity (ROE) | -29.4% | 9.2% | ARX | |
| 52-Week Range Position | 66% ($20–$61) | 100% ($9–$20) | ARX | |
| Beta / 30D Volatility | 1.48β · 96% Vol | -0.19β · 2% Vol | ARX | |
| Unified Institutional Score | 55.4 / 100 (HOLD) | 46.9 / 100 (HOLD) | HTFL | |
| Trailing 12M Revenue (USD) | $239M | $2.79B | Scale | |
| Gross Profit Margin (TTM) | 81.8% | 62.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 17.8x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$59M ($7.2M Net Cash) | $634M ($5.13B Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ARX +3.57 pp
3M Horizon
HTFL +2.02 pp
6M Horizon
HTFL +57.84 pp
1Y Horizon
HTFL +7.05 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HTFL Revenue | ARX Revenue | HTFL Op. Margin | ARX Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2023 | $90M | $340M | -83.6% | N/A | HTFL |
| FY2024 | $130M | $600M | -48.7% | N/A | HTFL |
| FY2025 | $180M | $910M | -36.4% | N/A | HTFL |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HTFL
CONSOLIDATION
Current IV
91.3%
IV Percentile
43rd %ile
Put/Call OI Skew
2.19x (Put-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
ACCUMULATION
Exact HTFL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ARX
CONSOLIDATION
Current IV
15.7%
IV Percentile
3rd %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HTFL Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
ARX Moat Profile
Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
OpEx & R&D Reinvestment
59.1% of Rev ($1.65B)
90D Engineering Disclosures
0 Published
Investor FAQ HTFL vs ARX Key Questions & Quantitative Answers
As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Heartflow, Inc. (HTFL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HTFL carries a Unified Composite Score of 55.4/100 (HOLD) at $46.86 (N/M Forward P/E, -30.0% operating margin), whereas ARX carries 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin). Composite vs. Pillar Nuance: While HTFL currently prints a higher short-term Unified Composite Score (55.4/100 HOLD vs. ARX 46.9/100 HOLD), ARX captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.7% vs. -30.0% operating margin) and revenue trajectory (+6.1% vs. +57.4% YoY).
ARX leads the Growth & Scale pillar: HTFL posts +57.4% YoY revenue growth and +0.0% YoY earnings growth on $239M TTM revenue (81.8% gross margin, -30.0% operating margin), compared with ARX at +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin). Across the 3-period historical trajectory (FY2023 to FY2025), HTFL cumulative revenue shifted +100.0% while ARX shifted +167.6%. In operating R&D and SG&A reinvestment, HTFL deploys N/A (0 90-day corporate R&D disclosures) versus 59.1% of Rev ($1.65B) (0 disclosures) for ARX.
ARX screens cheaper on headline valuation multiples. HTFL trades at N/M Forward P/E, 72.3x Trailing P/E, N/M PEG, and 17.8x EV/Revenue (-24.8% FCF margin), whereas ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HTFL (-29.4% ROE) versus ARX (9.2% ROE) capital efficiency.
In options market volatility and institutional positioning, HTFL carries 91.3% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 2.19x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.48β · 96% Vol realized risk). By comparison, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ARX vs HTFL · Reverse Pair
HTFL vs HNGE
· Sector Peer
HTFL vs BLLN
· Sector Peer
HTFL vs NAVN
· Sector Peer
ARX vs MH
· Sector Peer
ARX vs NIQ
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem